Clinical and Molecular Correlates of Escherichia coli Bloodstream Infection from Two Geographically Diverse Centers in Rochester, Minnesota, and Singapore.

Mendis, Shehara M; Vasoo, Shawn; Johnston, Brian D; Porter, Stephen B; Cunningham, Scott A; Menon, Sanjay R; Teng, Christine B; De, Partha P; Patel, Robin; Johnson, James R; Banerjee, Ritu

Mendis, Shehara M; Vasoo, Shawn; Johnston, Brian D; Porter, Stephen B; Cunningham, Scott A; Menon, Sanjay R; Teng, Christine B; De, Partha P; Patel, Robin; Johnson, James R; Banerjee, Ritu.

Afiliación

Mendis SM; Department of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.
Vasoo S; National Centre for Infectious Diseases, Singapore shawn_vasoo@ttsh.com.sg ritu.banerjee@vanderbilt.edu.
Johnston BD; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.
Porter SB; Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota, USA.
Cunningham SA; University of Minnesota, Minneapolis, Minnesota, USA.
Menon SR; Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
Teng CB; Department of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.
De PP; Department of Pharmacy, National University of Singapore, Singapore.
Patel R; Department of Pharmacy, Tan Tock Seng Hospital, Singapore.
Johnson JR; Department of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.
Banerjee R; Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.

Antimicrob Agents Chemother ; 62(10)2018 10.

Article en En | MEDLINE | ID: mdl-30082285

Asunto(s)

Infecciones por Escherichia coli/genética; Antibacterianos/farmacología; Bacteriemia/microbiología; Farmacorresistencia Bacteriana Múltiple/genética; Escherichia coli/efectos de los fármacos; Escherichia coli/patogenicidad; Infecciones por Escherichia coli/clasificación; Infecciones por Escherichia coli/tratamiento farmacológico; Proteínas de Escherichia coli/genética; Proteínas de Escherichia coli/metabolismo; Fluoroquinolonas/farmacología; Pruebas de Sensibilidad Microbiana; Minnesota; Epidemiología Molecular; Oportunidad Relativa; Estudios Retrospectivos; Singapur; Factores de Virulencia; beta-Lactamasas/genética; beta-Lactamasas/metabolismo

Palabras clave

Escherichia coli; H30Rx; ST131; bacteremia; medical outcomes; virulence factors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por Escherichia coli Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte / Asia Idioma: En Revista: Antimicrob Agents Chemother Año: 2018 Tipo del documento: Article País de afiliación: Singapur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google